Overview

A Study Designed to Determine if the Drugs Albuterol (Salbutamol) and Fluticasone Have an Effect on the Pharmacokinetics of the Investigational Product Technosphere® Insulin Inhalation Powder in Healthy Volunteers

Status:
Completed

Trial end date:
2008-10-01

Target enrollment:

Participant gender:

Summary

This study will investigate the effects of inhaled albuterol & fluticasone on one dose of TI Inhalation Powder. A total of 12 eligible subjects will be enrolled.

Phase:

Phase 1

Details

Lead Sponsor:

Mannkind Corporation

Treatments:

Albuterol
Fluticasone
Insulin
Insulin, Globin Zinc